Karoline Leavitt Gets Hysterical After Simple Question on ICE
But the protocols of the experiment not only legitimize these concerns, they raise them. Inside Medicine found that there was no placebo in the trial and that this experiment was studying a vaccine known to be effective to find “non-specific effects” of the vaccines. This is language straight from Health Secretary Robert F. Kennedy’s echo chamber, as he and his anti-vaccine colleagues baselessly claim that many vaccines have unknown harmful effects.
The study is also flawed because hepatitis B causes serious problems later in life, not soon after birth. It is therefore unlikely that attempting to measure mortality and morbidity will yield useful conclusions immediately. Additionally, none of the vaccines studied are approved by the FDA, raising the question of why the CDC is funding a study on vaccines that are not available to Americans.
Other problems with the trial include a lack of testing for hepatitis B in mothers, meaning some of the babies most at risk of contracting it could end up without a vaccine, and that there is no “stop” protocol in case results are very poor for participants. The Ministry of Health and Social Services defends the study by saying that Guinea-Bissau will not impose the hepatitis B vaccine before 2027 anyway.
